No effects of pulsed electromagnetic fields on expression of cell adhesion molecules (integrin, CD44) and matrix metalloproteinase-2/9 in osteosarcoma cell lines

Bioelectromagnetics

Volumn 32, Issue 6, 2011, Pages 463-473

  Zhang, Daguang ^a,b   Pan, Xin ^a,b   Ohno, Shuichiro ^a   Osuga, Tomoaki ^a   Sawada, Shigeyuki ^a   Sato, Keiji ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JILIN UNIVERSITY   (China)

Author keywords

CD44; Integrin; Matrix metalloproteinase 2 9; Metastasis; Osteosarcoma cells; PEMF

Indexed keywords

CELL ADHESION; CELL CULTURE; CELLS; CHEMOTHERAPY; ELECTROMAGNETIC FIELDS; ELECTROPHORESIS; ENZYME INHIBITION; PATHOLOGY; TUMORS;

CD44; CELL ADHESION MOLECULES; CELL LINES; ELECTROMAGNETIC FIELD EXPOSURE; INTEGRINS; MATRIX METALLOPROTEINASE-2; MATRIX METALLOPROTEINASE-2/9; METASTASIS; OSTEOSARCOMA CELLS; PULSED ELECTROMAGNETIC FIELDS;

MOLECULES;

ALPHA INTEGRIN; BETA INTEGRIN; CD44 PROTEIN, HUMAN; CELL ADHESION MOLECULE; GELATINASE A; GELATINASE B; HERMES ANTIGEN;

ANIMAL; ARTICLE; BONE TUMOR; ELECTROMAGNETIC FIELD; HUMAN; MAGNETOTHERAPY; METABOLISM; MOUSE; OSTEOSARCOMA; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD44; BONE NEOPLASMS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; ELECTROMAGNETIC FIELDS; HUMANS; INTEGRIN ALPHA CHAINS; INTEGRIN BETA CHAINS; MAGNETIC FIELD THERAPY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; OSTEOSARCOMA;

EID: 79960945328     PISSN: 01978462     EISSN: 1521186X     Source Type: Journal    
DOI: 10.1002/bem.20647     Document Type: Article

References (67)

1. Baguley BC. 2010. Multiple drug resistance mechanisms in cancer. Mol Biotechnol 46: 308-316.
2. Bashyam MD. 2002. Understanding cancer metastasis: An urgent need for using differential gene expression analysis. Cancer 94(6): 1821-1829.
3. Benazzo F, Cadossi M, Cavani F, Fini M, Giavaresi G, Setti S, Cadossi R, Giardino R. 2008. Cartilage repair with osteochondral autografts in sheep: Effect of biophysical stimulation with pulsed electromagnetic fields. J Orthop Res 26(5): 631-642.
4. Bersani F, Marinelli F, Ognibene A, Matteucci A, Cecchi S, Santi S, Squarzoni S, Maraldi NM. 1997. Intramembrane protein distribution in cell cultures was affected by 50Hz pulse magnetic fields. Bioelectromagnetics 18(7): 463-469.
5. Blank M, Goodman R. 2004. Initial interactions in electromagnetic field-induced biosynthesis. J Cell Physiol 199(3): 359-363.
6. Blank M, Goodman R. 2008. A mechanism for stimulation of biosynthesis by electromagnetic fields: Charge transfer in DNA and base pair separation. J Cell Physiol 214(1): 20-26.
7. Blank M. 2008. Protein and DNA reactions stimulated by electromagnetic fields. Electromagn Biol Med 27(1): 3-23.
8. Blumenthal NC, Ricci J, Breger L, Zychlinsky A, Solomon H, Chen GG, Kuznetsov D, Dorfman R. 1997. Effects of low-intensity AC and/or DC electromagnetic fields on cell attachment and induction of apoptosis. Bioelectromagnetics 18(3): 264-272.
9. Bogenrieder T, Herlyn M. 2003. Axis of evil: Molecular mechanisms of cancer metastasis. Oncogene 22(42): 6524-6536.
10. Cadossi R, Bersani F, Cossarizza A, Zucchini P, Emilia G, Torelli G, Franceschi C. 1992. Lymphocytes and low-frequency electromagnetic fields. Faseb J 6(9): 2667-2674.
11. Cane V, Botti P, Soana S. 1993. Pulsed magnetic fields improve osteoblast activity during the repair of an experimental osseous defect. J Orthop Res 11(5): 664-670.
12. Chakkalakal DA, Mollner TJ, Bogard MR, Fritz ED, Novak JR, McGuire MH. 1999. Magnetic field induced inhibition of human osteosarcoma cells treated with adriamycin. Cancer Biochem Biophys 17(1-2): 89-98.
13. Chou AJ, Geller DS, Gorlick R. 2008. Therapy for osteosarcoma: Where do we go from here? Paediatr Drugs 10(5): 315-327.
14. Chou AJ, Gorlick R. 2006. Chemotherapy resistance in osteosarcoma: Current challenges and future directions. Expert Rev Anticancer Ther 6(7): 1075-1085.
15. Cichy J, Pure E. 2003. The liberation of CD44. J Cell Biol 161(5): 839-843.
16. Ciombor DM, Aaron RK, Wang S, Simon B. 2003. Modification of osteoarthritis by pulsed electromagnetic field - A morphological study. Osteoarthritis Cartilage 11(6): 455-462.
17. Clark EA, Brugge JS. 1995. Integrins and signal transduction pathways: The road taken. Science 268(5208): 233-239.
18. De Mattei M, Caruso A, Traina GC, Pezzetti F, Baroni T, Sollazzo V. 1999. Correlation between pulsed electromagnetic fields exposure time and cell proliferation increase in human osteosarcoma cell lines and human normal osteoblast cells in vitro. Bioelectromagnetics 20(3): 177-182.
19. De Mattei M, Fini M, Setti S, Ongaro A, Gemmati D, Stabellini G, Pellati A, Caruso A. 2007. Proteoglycan synthesis in bovine articular cartilage explants exposed to different low-frequency low-energy pulsed electromagnetic fields. Osteoarthritis Cartilage 15(2): 163-168.
20. Diemel KD, Klippe HJ, Branseheid D. 2009. Pulmonary metastasetomy for osteosarcoma: is it justified? Recent Results Cancer Res 179: 183-208.
21. Gabizon A, Meshorer A, Barenholz Y. 1986. Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration. J Natl Cancer Inst 77(2): 459-469.
22. Giancotti FG, Ruoslahti E. 1999. Integrin signaling. Science 285(5430): 1028-1032.
23. Goodman R, Blank M. 2002. Insights into electromagnetic interaction mechanisms. J Cell Physiol 192(1): 16-22.
24. Hannan CJ Jr, Liang Y, Allison JD, Searle JR. 1994. In vitro cytotoxicity against human cancer cell lines during pulsed magnetic field exposure. Anticancer Res 14(4A): 1517-1520.
25. Hirata M, Kusuzaki K, Takeshita H, Hashiguchi S, Hirasawa Y, Ashihara T. 2001. Drug resistance modification using pulsing electromagnetic field stimulation for multidrug resistant mouse osteosarcoma cell line. Anticancer Res 21(1A): 317-320.
26. Hojilla CV, Mohammed FF, Khokha R. 2003. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 89(10): 1817-1821.
27. Hynes RO. 2002. Integrins: Bidirectional, allosteric signaling machines. Cell 110(6): 673-687.
28. Jasti AC, Wetzel BJ, Aviles H, Vesper DN, Nindl G, Johnson MT. 2001. Effect of a wound healing electromagnetic field on inflammatory cytokine gene expression in rats. Biomed Sci Instrum 37: 209-214.
29. Kim HJ, Chalmers PN, Morris CD. 2010. Pediatric osteogenic sarcoma. Curr Opin Pediatr 22(1): 61-66.
30. Klein G, Vellenga E, Fraaije MW, Kamps WA, de Bont ES. 2004. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g., acute leukemia. Crit Rev Oncol Hematol 50(2): 87-100.
31. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
32. Liang Y, Hannan CJ, Jr, Chang BK, Schoenlein PV. 1997. Enhanced potency of daunorubicin against multidrug resistant subline KB-ChR-8-5-11 by a pulsed magnetic field. Anticancer Res 17(3C): 2083-2088.
33. Liang BJ, Sato K, Yoshikawa K, Saga S. 2002. Effects of pulsing electromagnetic fields (PEMFs) on enhancement of anti-tumor agent on osteosarcoma cell lines - Establishment of the optimum condition on the PEMFs system and analysis of the mechanism. J Jpn Bio-Electri Res Soc 16: 43-44 (in Japanese).
34. Link M. 1993. Preoperative and adjuvant chemotherapy in osteosarcoma. Frontiers of Osteosarcoma Research: Interdisciplinary Survey of clinical and Research Advances. Seattle: Hogrefe and Huber. pp. 41-49.
35. Massari L, Fini M, Cadossi R, Setti S, Traina GC. 2006. Biophysical stimulation with pulsed electromagnetic fields in osteonecrosis of the femoral head. J Bone Joint Surg Am 88(Suppl. 3): 56-60.
36. Martin KH, Slack JK, Boerner SA, Martin CC, Parsons JT. 2002. Integrin connections map: To infinity and beyond. Science 296(5573): 1652-1653.
37. Martin TA, Harrison G, Mansel RE, Jiang WG. 2003. The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol 46(2): 165-186.
38. Matsumoto H, Ochi M, Abiko Y, Hirose Y, Kaku T, Sakaguchi K. 2000. Pulsed electromagnetic fields promote bone formation around dental implants inserted into the femur of rabbits. Clin Oral Implants Res 11(4): 354-360.
39. Messerschmitt PJ, Garcia RM, Abdul-Karim FW, Greenfield EM, Getty PJ. 2009. Osteosarcoma. J Am Acad Orthop Surg 17(8): 515-527.
40. Mialou V, Philip T, Kalifa C, Perol D, Gentet JC, Marec-Berard P, Pacquement H, Chastagner P, Defaschelles AS, Hartmann O. 2005. Metastatic osteosarcoma at diagnosis: Prognostic factors and long-term outcome - The French pediatric experience. Cancer 104(5): 1100-1109.
41. Miyagi N, Sato K, Rong Y, Yamamura S, Katagiri H, Kobayashi K, Iwata H. 2000. Effects of PEMF on a murine osteosarcoma cell line: Drug-resistant (P-glycoprotein-positive) and non-resistant cells. Bioelectromagnetics 21(2): 112-121.
42. Naor D, Sionov RV, Ish-Shalom D. 1997. CD44: Structure, function, and association with the malignant process. Adv Cancer Res 71: 241-319.
43. Omote Y. 1988. An experimental attempt to potentiate therapeutic effects of combined use of pulsing magnetic fields and antitumor agents. Nippon Geka Gakkai Zasshi 89(8): 1155-1166.
44. Omote Y, Hosokawa M, Komatsumoto M, Namieno T, Nakajima S, Kubo Y, Kobayashi H. 1990. Treatment of experimental tumors with a combination of a pulsing magnetic field and an antitumor drug. Jpn J Cancer Res 81(9): 956-961.
45. Pasquinelli P, Petrini M, Mattii L, Galimberti S, Saviozzi M, Malvaldi G. 1993. Biological effects of PEMF (pulsing electromagnetic field): An attempt to modify cell resistance to anticancer agents. J Environ Pathol Toxicol Oncol 12(4): 193-197.
46. Pezzetti F, De Mattei M, Caruso A, Cadossi R, Zucchini P, Carinci F, Traina GC, Sollazzo V. 1999. Effects of pulsed electromagnetic fields on human chondrocytes: An in vitro study. Calcif Tissue Int 65(5): 396-401.
47. Poste G, Fidler IJ. 1980. The pathogenesis of cancer metastasis. Nature 283(5743): 139-146.
48. Quigley JP, Armstrong PB. 1998. Tumor cell intravasation alu-cidated: The chick embryo opens the window. Cell 94(3): 281-284.
49. Rong Y, Sato K, Iwata H, Miyagi N. 1996. Combination of PEMF (pulsing electromagnetic field) and chemothrapy in experimental tumor: An attempt to enhance cytocidal effect of antitumor agent. J Jpn Bio-Electri Res Soc 10: 83-86 (in Japanese).
50. Ruiz-Gomez MJ, de la Pena L, Prieto-Barcia MI, Pastor JM, Gil L, Martinez-Morillo M. 2002. Influence of 1 and 25Hz, 1.5mT magnetic fields on antitumor drug potency in a human adenocarcinoma cell line. Bioelectromagnetics 23(8): 578-585.
51. Santini MT, Rainaldi G, Ferrante A, Indovina PL, Vecchia P, Donelli G. 2003. Effects of a 50Hz sinusoidal magnetic field on cell adhesion molecule expression in two human osteosarcoma cell lines (MG-63 and Saos-2). Bioelectromagnetics 24(5): 327-338.
52. Satter Syed A, Islam MS, Rabbani KS, Talukder MS. 1999. Pulsed electromagnetic fields for the treatment of bone fractures. Bangladesh Med Res Counc Bull 25(1): 6-10.
53. Shah JP, Midkiff P, Brandt PC, Sisken BF. 2001. Growth and differentiation of PC6 cells: The effects of pulsed electromagnetic fields (PEMF). Bioelectromagnetics 22(4): 267-271.
54. Short WO, Goodwill L, Taylor CW, Job C, Arthur ME, Cress AE. 1992. Alteration of human tumor cell adhesion by high-strength static magnetic fields. Invest Radiol 27(10): 836-840.
55. Simkó M, Mattsson MO. 2004. Extremely low frequency electromagnetic fields as effectors of cellular responses in vitro: Possible immune cell activation. J Cell Biochem 93(1): 83-92.
56. Sollazzo V, Traina GC, DeMattei M, Pellati A, Pezzetti F, Caruso A. 1997. Responses of human MG-63 osteosarcoma cell line and human osteoblast-like cells to pulsed electromagnetic fields. Bioelectromagnetics 18(8): 541-547.
57. Takagi J, Springer TA. 2002. Integrin activation and structural rearrangement. Immunol Rev 186: 141-163.
58. Traitcheva N, Berg H. 2010. Electroporation and alternating current cause membrane permeation of photodynamic cytotoxins yielding necrosis and apoptosis of cancer cells. Bioelectrochemistry 79(2): 257-260.
59. Trieb K, Kotz R. 2001. Proteins expressed in osteosarcoma and serum levels as prognostic factors. Int J Biochem Cell Biol 33(1): 11-17.
60. Uchida A, Myoui A, Araki N, Yoshikawa H, Shinto Y, Ueda T. 1997. Neoadjuvant chemotherapy for pediatric osteosarcoma patients. Cancer 79(2): 411-415.
61. Varani K, Gessi S, Merighi S, Iannotta V, Cattabriga E, Spisani S, Cadossi R, Borea PA. 2002. Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. Br J Pharmacol 136(1): 57-66.
62. Ward WG, Mikaelian K, Dorey F, Mirra JM, Sassoon A, Holmes EC, Eilber FR, Eckardt JJ. 1994. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 12(9): 1849-1858.
63. Weber GF. 2001. The metastasis gene osteopontin: A candidate target for cancer therapy. Biochim Biophys Acta 1552(2): 61-85.
64. Wolf FI, Torsello A, Tedesco B, Fasanella S, Boninsegna A, D'Ascenzo M, Grassi C, Azzena GB, Cittadini A. 2005. 50-Hz extremely low frequency electromagnetic fields enhance cell proliferation and DNA damage: Possible involvement of a redox mechanism. Biochim Biophys Acta 1743(1-2): 120-129.
65. Yonemori K, Matsunaga S, Ishidou Y, Maeda S, Yoshida H. 1996. Early effects of electrical stimulation on osteogenesis. Bone 19(2): 173-180.
66. Yu Q, Stamenkovic I. 1999. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13(1): 35-48.
67. Yu Q, Stamenkovic I. 2000. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14(2): 163-176.